Business Description
Bio Vitos Pharma AB
ISIN : SE0009320278
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.97 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 16.39 | |||||
Beneish M-Score | -0.97 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.1 | |||||
3-Year EBITDA Growth Rate | 41.5 | |||||
3-Year EPS without NRI Growth Rate | 59.5 | |||||
3-Year FCF Growth Rate | 51.2 | |||||
3-Year Book Growth Rate | -59.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.04 | |||||
9-Day RSI | 22.65 | |||||
14-Day RSI | 26.91 | |||||
6-1 Month Momentum % | 14.86 | |||||
12-1 Month Momentum % | -26.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.07 | |||||
Quick Ratio | 4.27 | |||||
Cash Ratio | 3.05 | |||||
Days Inventory | 411.26 | |||||
Days Sales Outstanding | 36.59 | |||||
Days Payable | 157.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -147.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.29 | |||||
Operating Margin % | -430.05 | |||||
Net Margin % | -428.12 | |||||
FCF Margin % | -132.05 | |||||
ROE % | -54.9 | |||||
ROA % | -45.58 | |||||
ROIC % | -44.92 | |||||
ROC (Joel Greenblatt) % | -958.22 | |||||
ROCE % | -54.9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.68 | |||||
PB Ratio | 1.07 | |||||
Price-to-Tangible-Book | 5.98 | |||||
EV-to-EBIT | -2.62 | |||||
EV-to-EBITDA | -9.78 | |||||
EV-to-Revenue | 11.21 | |||||
EV-to-FCF | -8.49 | |||||
Price-to-Net-Current-Asset-Value | 11.95 | |||||
Price-to-Net-Cash | 11.95 | |||||
Earnings Yield (Greenblatt) % | -38.17 | |||||
FCF Yield % | -11.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bio Vitos Pharma AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 3.005 | ||
EPS (TTM) (kr) | -0.265 | ||
Beta | 0 | ||
Volatility % | 95.69 | ||
14-Day RSI | 26.91 | ||
14-Day ATR (kr) | 0.020484 | ||
20-Day SMA (kr) | 0.176325 | ||
12-1 Month Momentum % | -26.45 | ||
52-Week Range (kr) | 0.0848 - 0.4 | ||
Shares Outstanding (Mil) | 294.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bio Vitos Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bio Vitos Pharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Bio Vitos Pharma AB Frequently Asked Questions
What is Bio Vitos Pharma AB(OSTO:BIOVIT)'s stock price today?
When is next earnings date of Bio Vitos Pharma AB(OSTO:BIOVIT)?
Does Bio Vitos Pharma AB(OSTO:BIOVIT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |